Brendon Neuen's Publications

About Brendon Neuen's Publications

Program Lead, Renal and Metabolic
  • Nephrologist and Director, Kidney Trials, Royal North Shore Hospital
  • Clinical Associate Professor, University of Sydney
  • Conjoint Associate Professor, UNSW Sydney
  • Ph.D. ,
  • MBBS(Hons),
  • MSc(Oxon),
  • FRACP,
  • FASN

  • Decline in glomerular filtration rate as an endpoint in heart failure clinical trials: challenges and solutions

    European Heart Journal Date published:

  • Changing paradigms of studies in kidney diseases

    Kidney International Date published:

  • Quality of care for people with chronic kidney disease: a systematic review and meta-analysis

    BMJ Open Date published:

  • Cardiovascular, kidney, and metabolic health: an actionable vision for heart failure prevention

    The Lancet Date published:

  • Natriuretic Peptides, Body Mass Index, and Clinical Outcomes in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

    JACC Date published:

  • Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction

    JACC: Heart Failure Date published:

  • Combining SGLT2i and MRAs in Heart Failure

    Journal of the American College of Cardiology Date published:

  • Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset

    Diabetes, Obesity and Metabolism Date published:

  • SGLT2 Inhibition and Hospitalizations in Patients with CKD: A Meta-Analysis of Kidney Outcome Trials

    Clinical Journal of the American Society of Nephrology Date published:

  • Albuminuria, Kidney Function and Heart Failure Risk in Type 2 Diabetes: Participant-level pooled analysis from CANVAS Program and CREDENCE trial

    Journal of Cardiac Failure Date published:

  • Variation in uptake of sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor analogues in adults with type 2 diabetes at high cardiovascular risk

    European Journal of Clinical Pharmacology Date published:

  • Renal Dysfunction Across the Spectrum of Cardiogenic Shock: Mechanisms, Clinical Implications, and Therapeutic Strategies

    Current Heart Failure Reports Date published:

  • Trends in use of sodium-glucose cotransporter 2 inhibitors among people with type 2 diabetes following hospitalisation with heart failure: A population-based study

    Diabetes Research and Clinical Practice Date published:

  • Corticosteroid Effects in IgA Nephropathy by Baseline Proteinuria and Estimated GFR

    Kidney International Reports Date published:

  • Clinical Implications of Slope of GFR in Clinical Trials of CKD Progression

    Clinical Journal of the American Society of Nephrology Date published:

  • Assessing patterns of chronic kidney disease care in Australian primary care: a retrospective cohort study of a national general practice dataset

    The Lancet Regional Health - Western Pacific Date published: